CEPI and POP BIO are committed to enabling equitable access to the outputs of their partnership, in line with CEPI’s ...
Global health organisation CEPI has committed approximately $60 million to Moderna (NASDAQ:MRNA) and two additional research ...
CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot ...
Moderna MRNA announced a new collaboration with the Coalition for Epidemic Preparedness Innovations (“CEPI”) to accelerate ...
The Coalition for Epidemic Preparedness Innovations (CEPI) has made $60 million available for clinical trials of vaccines for ...
By Jennifer Rigby, Mariam Sunny and Siddhi Mahatole June 1 (Reuters) - Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of ...
As the Ebola epidemic raging in the Democratic Republic of the Congo shows no signs of abating, researchers around the world ...
Under the plans, CEPI has committed up to $50 million to US-based Moderna for preclinical development and Phase 1 clinical ...
Moderna (NasdaqGS:MRNA) has expanded its collaboration with CEPI to accelerate development of an mRNA vaccine targeting ...
Coalition for Epidemic Preparedness Innovations funding builds on Moderna's prior filovirus research and supports ...
There is no licensed vaccine for the current Bundibugyo strain, with Moderna, the University of Oxford and IAVI, all hoping ...